BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37716031)

  • 1. Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM/CCL5-mediated osteoclastogenesis.
    Chen C; Wang S; Wang N; Zheng Y; Zhou J; Hong M; Chen Z; Wang S; Wang Z; Xiang S
    Phytomedicine; 2023 Nov; 120():155076. PubMed ID: 37716031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
    Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
    Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells.
    Kavitha CV; Deep G; Gangar SC; Jain AK; Agarwal C; Agarwal R
    Mol Carcinog; 2014 Mar; 53(3):169-80. PubMed ID: 23115104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling.
    Huang R; Wang S; Wang N; Zheng Y; Zhou J; Yang B; Wang X; Zhang J; Guo L; Wang S; Chen Z; Wang Z; Xiang S
    Cell Death Dis; 2020 Apr; 11(4):234. PubMed ID: 32300100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.
    Yeh CR; Slavin S; Da J; Hsu I; Luo J; Xiao GQ; Ding J; Chou FJ; Yeh S
    Mol Cancer; 2016 Jan; 15():7. PubMed ID: 26790618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5).
    Wintges K; Beil FT; Albers J; Jeschke A; Schweizer M; Claass B; Tiegs G; Amling M; Schinke T
    J Bone Miner Res; 2013 Oct; 28(10):2070-80. PubMed ID: 23553711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
    Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
    Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways.
    Xu Q; Chen G; Liu X; Dai M; Zhang B
    Biochem Biophys Res Commun; 2019 Jan; 508(3):902-906. PubMed ID: 30538045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
    Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway.
    Wang S; Wang N; Huang X; Yang B; Zheng Y; Zhang J; Wang X; Lin Y; Wang Z
    Phytomedicine; 2020 Nov; 78():153331. PubMed ID: 32911383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
    Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
    Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
    Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
    Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer.
    Kong D; Ye C; Zhang C; Sun X; Wang F; Chen R; Xiao G; He S; Xu J; Rao X; Ai J; Gao X; Li H; Su L
    J Exp Clin Cancer Res; 2023 Feb; 42(1):45. PubMed ID: 36759880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
    Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
    Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
    Cha HR; Lee JH; Hensel JA; Sawant AB; Davis BH; Lee CM; Deshane JS; Ponnazhagan S
    Prostate; 2016 May; 76(7):624-36. PubMed ID: 26856684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.
    Xiang P; Jin S; Yang Y; Sheng J; He Q; Song Y; Yu W; Hu S; Jin J
    Prostate; 2019 Jun; 79(9):1018-1031. PubMed ID: 31018021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.
    Watanabe K; Hirata M; Tominari T; Matsumoto C; Fujita H; Yonekura K; Murphy G; Nagase H; Miyaura C; Inada M
    J Biol Chem; 2016 Sep; 291(40):20891-20899. PubMed ID: 27539855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p.
    Yu L; Sui B; Fan W; Lei L; Zhou L; Yang L; Diao Y; Zhang Y; Li Z; Liu J; Hao X
    J Extracell Vesicles; 2021 Jan; 10(3):e12056. PubMed ID: 33489015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-C Motif Chemokine Ligand 5 (CCL5) Promotes Irradiation-Evoked Osteoclastogenesis.
    Wang J; Zhao F; Xu L; Wang J; Zhai J; Ren L; Zhu G
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.